Einträge von numaferm-admin

NUMAFERM wins Start Me Up! award

Düsseldorf based biotech startup NUMAFERM wins BILANZ start up competition „Start Me Up!“ and receives 100.000 Euros. Jury-head, serial-entreapreneur and Silicon-Valley investor Andy Bechtolsheim about the decision: „Three aspects are important for venture capitalists: firstly, the team, secondly, the technology and thirdly, the potential market success. All three factors are important but most important is […]

Deutsche Biotechnologietage 2018, Berlin

NUMAFERM nimmt an den diesjährigen Deutschen Biotechnologietagen 2018 teil, welche zwischen dem 18. und 19. April in Berlin stattfinden werden. Unser CEO, Dr. Christian Schwarz, wird am 18. April um 16:00 Uhr an einem Symposium des Bereichs industrielle Biotechnologie mit dem Titel „Think Big. Biomoleküle im Großmaßstab“ teilnehmen und dort präsentieren. Wir freuen uns darauf […]

TIDES 2018, Boston

NUMAFERM’s CEO Dr. Christian Schwarz is going to take part in the 2018 TIDES Convention, that takes place in Boston in May. TIDES is the largest meeting to accelerate peptide products from early discovery to late-stage development & commercialization. Please get in contact with Christian (christian.schwarz@numaferm.com) in order to pre-arrange one-on-one meetings. We are looking […]

NUMAFERM closes Seed-Round

The Dusseldorf university spin-off NUMAFERM specializes in the biotechnical production of peptides and is able, through its newly developed platform technology, to dramatically reduce costs for this raw material. For the further technological development and an accelerated market entry, NUMAFERM GmbH is now receiving funding in the seven-digit range. High-Tech Gründerfonds (HTGF), Qiagen co-founders and […]